| less than a minute read
ALZHEIMER’S DRUG DEVELOPMENT COMPANY COGNITION THERAPEUTICS APPOINTS KENNETH I. MOCH PRESIDENT & CEO
Get in touch
Get in touch
Cognition Therapeutics, Inc., a clinical stage neuroscience therapeutics company, announced today that Kenneth I. Moch has been appointed President and Chief Executive Officer of the company. Mr. Moch will also join the company’s Board of Directors.
Get in touch
Get in touch
Latest Insights
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-15-32-04-091-6a7205f4b4306b41266d92f2.jpg)
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-18-23-13-222-6a722e11663e81e26a6b2c3e.jpg)
